Cargando…

A multiscale agent-based model of ductal carcinoma in situ

OBJECTIVE: we present a multiscale agent-based model of Ductal Carcinoma in Situ (DCIS) in order to gain a detailed understanding of the cell-scale population dynamics, phenotypic distributions, and the associated interplay of important molecular signaling pathways that are involved in DCIS ductal i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Butner, Joseph D., Fuentes, David, Ozpolat, Bulent, Calin, George A., Zhou, Xiaobo, Lowengrub, John, Cristini, Vittorio, Wang, Zhihui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445608/ https://www.ncbi.nlm.nih.gov/pubmed/31603768 http://dx.doi.org/10.1109/TBME.2019.2938485

Ejemplares similares

Dedifferentiation-mediated stem cell niche maintenance in early-stage ductal carcinoma in situ progression: insights from a multiscale modeling study
por: Butner, Joseph D., et al.
Publicado: (2022)

Translational Modeling Identifies Synergy between Nanoparticle-Delivered miRNA-22 and Standard-of-Care Drugs in Triple-Negative Breast Cancer
por: Dogra, Prashant, et al.
Publicado: (2022)

Protocol for mathematical prediction of patient response and survival to immune checkpoint inhibitor immunotherapy
por: Butner, Joseph D., et al.
Publicado: (2022)

A Novel, Patient-Specific Mathematical Pathology Approach for Assessment of Surgical Volume: Application to Ductal Carcinoma in situ of The Breast
por: Edgerton, Mary E., et al.
Publicado: (2011)

A Computational Model for Predicting Nanoparticle Accumulation in Tumor Vasculature
por: Frieboes, Hermann B., et al.
Publicado: (2013)

Mathematical modeling in cancer nanomedicine: a review
por: Dogra, Prashant, et al.
Publicado: (2019)

A mathematical model to predict nanomedicine pharmacokinetics and tumor delivery
por: Dogra, Prashant, et al.
Publicado: (2020)

Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer
por: Wei, Zhang, et al.
Publicado: (2012)

Ductal carcinoma in situ (DCIS)
por: Holland, R
Publicado: (2002)

Ductal Carcinoma In Situ of the Breast
por: Lee, Richard J., et al.
Publicado: (2012)

Breast Ductal Carcinoma In Situ
por: Sacchini, Virgilio, et al.
Publicado: (2012)

Clinical and imaging characteristics of breast ductal carcinoma in situ with microinvasion
por: Han, Sijia, et al.
Publicado: (2020)

Modeling Human Ductal Carcinoma In Situ in the Mouse
por: Behbod, Fariba, et al.
Publicado: (2018)

Imaging of Noncalcified Ductal Carcinoma In Situ
por: Bragg, Ashley, et al.
Publicado: (2021)

Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer
por: Kim, Shinn Young, et al.
Publicado: (2015)

Comparison of breast ductal carcinoma in situ and ductal carcinoma in situ with microinvasion, and analysis of axillary lymph node metastasis
por: Zhang, Geng, et al.
Publicado: (2020)

Non-coding RNAs regulation of macrophage polarization in cancer
por: Mohapatra, Swati, et al.
Publicado: (2021)

miRacle of microRNA-Driven Cancer Nanotherapeutics
por: Kara, Goknur, et al.
Publicado: (2022)

Mouse intraductal modeling of primary ductal carcinoma in situ
por: Hutten, Stefan J., et al.
Publicado: (2023)

Mathematical Oncology: How Are the Mathematical and Physical Sciences Contributing to the War on Breast Cancer?
por: Chauviere, Arnaud H., et al.
Publicado: (2010)

ncRNA therapy with miRNA-22-3p suppresses the growth of triple-negative breast cancer
por: Gorur, Aysegul, et al.
Publicado: (2021)

Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ
por: Takada, Koji, et al.
Publicado: (2020)

A new model for ductal carcinoma in situ suggests strategies for treatment
por: Gullick, William John
Publicado: (2002)

Genetic predisposition to ductal carcinoma in situ of the breast
por: Petridis, Christos, et al.
Publicado: (2016)

Immunohistochemical categorisation of ductal carcinoma in situ of the breast
por: Meijnen, P, et al.
Publicado: (2008)

Magnetic resonance imaging of ductal carcinoma in situ
por: Kuhl, C
Publicado: (2008)

Ductal carcinoma in situ (DCIS): are we overdetecting it?
por: Evans, A
Publicado: (2004)

Ductal carcinoma in situ (DCIS): are we overtreating it?
por: Dixon, JM
Publicado: (2004)

Status of Intraductal Therapy for Ductal Carcinoma in Situ
por: Flanagan, Meghan, et al.
Publicado: (2010)

DNA methylation in ductal carcinoma in situ of the breast
por: Pang, Jia-Min B, et al.
Publicado: (2013)

Tamoxifen Initiation After Ductal Carcinoma In Situ
por: Nichols, Hazel B., et al.
Publicado: (2016)

Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis
por: Gorringe, Kylie L., et al.
Publicado: (2017)

Ductal carcinoma in situ: to treat or not to treat, that is the question
por: van Seijen, Maartje, et al.
Publicado: (2019)

Potential biomarkers of ductal carcinoma in situ progression
por: Dettogni, Raquel Spinassé, et al.
Publicado: (2020)

Educational Case: Ductal Carcinoma In Situ (DCIS)
por: Komforti, Miglena K., et al.
Publicado: (2019)

Is conservative management of ductal carcinoma in situ risky?
por: Zheng, Lan, et al.
Publicado: (2022)

Concurrent Granulomatous Mastitis and Ductal Carcinoma In Situ
por: Yoshida, Nana, et al.
Publicado: (2023)

Features of ductal carcinoma in situ ultrasound images
por: Watanabe, Takanori
Publicado: (2023)

A clinical radiomics nomogram preoperatively to predict ductal carcinoma in situ with microinvasion in women with biopsy-confirmed ductal carcinoma in situ: a preliminary study
por: Huang, Zhou, et al.
Publicado: (2023)

Ductal Carcinoma In Situ Progression in Dog Model of Breast Cancer
por: I. Mohammed, Sulma, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vari5ue235scpugj7vk7ni1iq4